Cationic ammonium surfactants as low dosage hydrate inhibitors
US-2016122619-A1 · May 5, 2016 · US
US10435616B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10435616-B2 |
| Application number | US-201515522906-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 30, 2015 |
| Priority date | Oct 30, 2014 |
| Publication date | Oct 8, 2019 |
| Grant date | Oct 8, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This disclosure relates to anti-agglomerant low dosage hydrate inhibitors that can inhibit the formation of hydrate agglomerants and/or plugs. The anti-agglomerant low dosage hydrate inhibitors can be surfactants. The hydrate inhibitors can be used for inhibiting, retarding, mitigating, reducing, controlling and/or delaying formation of hydrocarbon hydrates, agglomerants of hydrates, and/or plugs. The hydrate inhibitors can be applied to prevent, reduce, and/or mitigate plugging of conduits, pipes, transfer lines, valves, and other places or equipment where hydrocarbon hydrate solids can form. The hydrate inhibitors can be zwitterionic or cationic ammonium surfactants.
Opening claim text (preview).
What is claimed is: 1. A hydrate inhibitor composition comprising a hydrate-inhibiting effective amount of a compound of Formula (I), or an acid, a free base, a zwitterion, or a salt thereof: wherein R 1 is hydrogen, a C 1 to C 20 substituted or unsubstituted alkyl group, or a C 1 to C 20 substituted or unsubstituted alkenyl group; R 2 is an alkylcarboxyl, or an alkylamido group; R 4 is hydrogen, a C 1 to C 20 substituted or unsubstituted alkyl group, or a C 1 to C 20 substituted or unsubstituted alkenyl group; R 5 is C 10 to C 20 alkyl or —R 50 —NR 6 R 7 , wherein R 50 is C 1 to C 5 alkylene, and R 6 and R 7 are independently C 1 to C 6 alkyl; and R 8 is a C 2 to C 10 substituted or unsubstituted alkylene group. 2. The composition of claim 1 , wherein the substituted alkyl group of R 1 and R 4 has at least one of the —CH 2 — groups in the chain replaced with an ether, an amine, an amide, a carbonyl, or an ester functional group or at least one of the hydrogen atoms attached to a carbon atom of the chain is replaced with a hydroxy, a halo, or an amine group. 3. The composition of claim 2 , wherein the substituted alkyl group of R 1 and R 4 has at least one of the —CH 2 — groups in the chain replaced with an amine. 4. The composition of claim 1 , wherein R 8 is —C 2 H 4 —. 5. The composition of claim 4 , wherein R 1 is C 10 to C 20 alkyl or —R 10 —NR 6 R 7 , wherein R 10 is C 1 to C 5 alkylene, and R 6 and R 7 are independently substituted or unsubstituted C 1 to C 6 alkyl. 6. The composition of claim 1 , wherein R 2 is —R 20 —C(O)O − , wherein R 20 is C 1 to C 4 alkylene. 7. The composition of claim 1 , wherein R 4 is hydrogen. 8. The composition of claim 6 , wherein R 20 is C 2 H 4 , and R 50 is C 3 H 6 . 9. The composition of claim 1 , wherein when the compound is in its salt form, the counterion is selected from the group consisting of a halide, a carboxylate, hydrogen sulfate, dihydrogen phosphate, nitrate, and a combination thereof. 10. The composition of claim 9 , wherein the counterion is an acetate, an acrylate, or a combination thereof. 11. The composition of claim 1 , wherein the composition further comprises a thermodynamic hydrate inhibitor, a kinetic hydrate inhibitor, an anti-agglomerant, or a combination thereof. 12. The composition of claim 1 , wherein the composition further comprises a polar solvent, a nonpolar solvent, or a mixture thereof. 13. A method of inhibiting formation of hydrate agglomerants in a fluid comprising water, a gas, and optionally a liquid hydrocarbon, comprising contacting the fluid with an effective amount of a hydrate inhibitor composition of claim 1 . 14. The method of claim 13 , wherein the effective amount is from about 0.1 to about 10 volume %, based on an amount of water. 15. A hydrate inhibitor composition comprising a hydrate-inhibiting effective amount of: wherein R 11 is C 8 to C 20 alkyl, and R 12 and R 13 are independently C 1 to C 6 alkyl. 16. The composition of claim 15 wherein the compound of Formula 1 is:
having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title
Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning · CPC title
Hydrates inhibition by using well treatment fluids containing inhibitors of hydrate formers · CPC title
having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.